Skip to main content


Figure 5 | BMC Ophthalmology

Figure 5

From: Efficacy of topical cobalt chelate CTC-96 against adenovirus in a cell culture model and against adenovirus keratoconjunctivitis in a rabbit model

Figure 5

Averages ± standard deviations of plaque assay viral titers [plaque forming units (pfu)/ml] of CTC-treated animals by group. Placebo (squares, solid line); 50 ug/ml, 9x/day ["50/9" (triangles, dotted line)]; 50 ug/ml, 6x/day ["50/6" (diamonds, mixed solid/dotted line)]; 258 ug/ml, 6x/day ["25/6" (asterisks/circles, dashed line)].

Back to article page